- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/10 - Drugs for disorders of the urinary system of the bladder
Patent holdings for IPC class A61P 13/10
Total number of patents in this class: 918
10-year publication summary
43
|
34
|
61
|
61
|
69
|
84
|
56
|
76
|
38
|
20
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Astellas Pharma Inc. | 1087 |
39 |
Takeda Pharmaceutical Company Limited | 2711 |
22 |
Shionogi & Co., Ltd. | 860 |
19 |
TARIS Biomedical LLC | 133 |
19 |
KYORIN Pharmaceutical Co., Ltd. | 168 |
17 |
ASKA Pharmaceutical Co., Ltd. | 100 |
14 |
Allergan, Inc. | 2356 |
13 |
Nippon Shinyaku Co., Ltd. | 327 |
12 |
Taisho Pharmaceutical Co., Ltd. | 870 |
12 |
Ono Pharmaceutical Co., Ltd. | 434 |
11 |
Urovant Sciences GmbH | 59 |
11 |
Kissei Pharmaceutical Co., Ltd. | 187 |
10 |
Theravida, Inc. | 31 |
10 |
Farco-pharma GmbH | 70 |
9 |
Santa Farma İlaç Sanayi̇ A.ş. | 58 |
9 |
Daiichi Sankyo Company, Limited | 1865 |
8 |
Glaxosmithkline Intellectual Property (no.2) Limited | 288 |
7 |
Mochida Pharmaceutical Co., Ltd. | 338 |
7 |
Toray Industries, Inc. | 6931 |
6 |
Sanovel Ilac Sanayi ve Ticaret A.S. | 283 |
6 |
Other owners | 657 |